Strong Genetic

Agenesis of the Corpus Callosum with Peripheral Neuropathy (Andermann Syndrome)

GeneSLC12A6rsIDrs80358228InheritanceAutosomal recessiveCarrier frequency~1 in 23 in Charlevoix-Saguenay (Quebec), rare elsewhereSystemCarrier Screening

Summary

Andermann syndrome is a neurological condition combining two features: absence or underdevelopment of the corpus callosum (the major connection between the brain's two hemispheres) and progressive sensorimotor peripheral neuropathy. The SLC12A6 gene encodes a potassium-chloride cotransporter important for neuronal development and function.

Practical takeaway

Relevant primarily if your partner is of French Canadian descent. A carrier test can determine partner status. Realised does not calculate reproductive risk or advise on reproductive decisions.

Evidence detail

What Carrier Status Means For You

You are not affected. One working copy of SLC12A6 is sufficient. Standard 25/50/25 recessive inheritance applies.

Population Context

The T813fsX founder mutation gives the Charlevoix-Saguenay region of Quebec a carrier frequency of ~1 in 23 — remarkably high. Named after neurologist Frederick Andermann who described it. Outside French Canada, the condition is extremely rare.

Limitations

23andMe tests 1 SLC12A6 variant. Coverage is limited to the French Canadian founder mutation. Comprehensive sequencing is needed for non-French-Canadian individuals.

Open in the Library: search, filter, every entry →

We set no cookies and run no ad trackers. We count visits with Cloudflare's cookieless, privacy-first analytics. The only thing stored on your device is which example you last viewed.